Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02236572
Title Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk Score
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Yale University
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Yale University New Haven Connecticut 06520 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field